Although the first involvement of NRF2 in cancer was discovered in hepatocellular carcinoma [83], further experiments found elevated NRF2 protein levels in other malignancies, such as lung cancer [73,74]. Here, NFE2L2 is linked to hepatocellular carcinoma.